Skip to main content
Marjorie Green, MD, Oncology, Bothell, WA

MarjorieGreenMD

Oncology Bothell, WA

Breast Cancer, Hematologic Oncology

SVP, Late Stage Clinical Development

Dr. Green is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Green's full profile

Already have an account?

  • Office

    21717 30th Dr SE
    Bothell, WA 98021
    Phone+1 425-527-4340

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1998 - 2001
  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Internal Medicine, 1995 - 1998
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 1995

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2000 - 2026

Publications & Presentations

PubMed

Press Mentions

  • Merck Welireg Receives European Commission Nod for Two Indications
    Merck Welireg Receives European Commission Nod for Two IndicationsFebruary 18th, 2025
  • Merck WELIREG Gets USFDA Priority for Advanced Pheochromocytoma and Paraganglioma
    Merck WELIREG Gets USFDA Priority for Advanced Pheochromocytoma and ParagangliomaJanuary 27th, 2025
  • Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
    Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with PembrolizumabDecember 16th, 2024
  • Join now to see all